...
首页> 外文期刊>Pediatric radiology >Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea
【24h】

Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea

机译:唾液腺消融:在唾液酸管理中引入介入放射治疗替代品

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Sialorrhea is common in children with neurological disorders and leads to social isolation, aspiration pneumonia and increased caregiver burden. Sialorrhea management includes anticholinergic medications and a variety of surgeries, but these are limited by side effects, recurrence and risks. Objective We present our method of salivary gland ablation, an interventional radiology treatment for sialorrhea, and report safety and efficacy data from pediatric patients who underwent salivary gland ablation. Materials and methods Salivary gland ablation uses image-guided sotradecol and ethanol dual-drug injection into the salivary glands. Submandibular and sublingual glands are injected percutaneously using ultrasound. Parotid glands are injected retrograde through Stensen ducts using fluoroscopy. We conducted a retrospective review of the medical records of patients who underwent salivary gland ablation at our institution between 2005 and 2019. Pre- and post-procedure Drooling Frequency and Drooling Severity (DFDS) scale scores were compared and caregiver satisfaction was assessed. We devised two cohorts, one to study patient safety and a subcohort to study clinical efficacy using DFDS scores. Results One hundred and seventy salivary gland ablation procedures were performed in the 99 patients comprising the safety cohort. Of the procedures, 88.8% resulted in no or minimal complications. Respiratory difficulty, temporary nerve palsy and infection represent the majority of the 11.2% of patients who experienced periprocedural complications. There were no complications resulting in permanent sequelae. Twenty-seven patients met our inclusion criteria for the efficacy subcohort with a mean follow-up time of 5.4 years. DFDS at follow-up decreased from a median score of nine to a seven post-procedure (P=0.000018). The proportion of caregivers who were satisfied with the procedure increased as more glands were ablated, which suggests a causal link between the number of glands ablated and the outcome. Conclusion Salivary gland ablation is a safe and effective procedure with the potential for permanent decrease in symptoms related to sialorrhea.
机译:背景技术唾液酸是患有神经系统疾病的儿童,并导致社会孤立,患有患有肺炎和护理人员负担增加。唾液酸管理包括抗胆碱能药物和各种手术,但这些是受副作用,复发和风险的限制。目的我们介绍了我们的唾液腺烧蚀方法,血液血液介入放射学治疗,以及从唾液腺消融的儿科患者报告安全性和疗效数据。材料和方法唾液腺消融使用图像引导的SOTRADECOL和乙醇双药物注射到唾液腺中。潜水和舌下腺体经皮注射超声波。使用荧光检查通过Stensen管道注入腮腺逆行。我们对2005年至2019年期间在我们的机构接受了唾液腺融合的患者的病历进行了回顾性审查。比较预先和术后流口水和流口水的严重程度(DFDS)规模分数并评估了护理人员满意度。我们设计了两个队列,一个队伍,一个来学习患者安全和子桥,以研究使用DFDS评分研究临床疗效。结果99例患有安全队列的99例患者进行了一百七十唾液腺消融程序。该程序,88.8%导致无或最小的并发症。呼吸困难,临时神经麻痹和感染代表了大多数人经历了群体的患者的患者。永久性后遗症没有并发症。二十七名患者达到了疗效亚脉络表的纳入标准,其平均随访时间为5.4岁。随访中的DFD从九个后续得分降低到七个过程(P = 0.000018)。随着更多腺体的烧蚀,对程序感到满意的护理人员的比例增加,这表明腺体数量和结果之间的因果关系。结论唾液腺消融是一种安全有效的程序,具有与唾液酸有关的症状永久性降低的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号